$7.17 +0.07 (%) Compugen Ltd - NASDAQ

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 11, 2014 | 10:18AM EST
  2. Compugen Discloses Successful Validation Results For Novel B7/CD28–like Cancer Immunotherapy Target Candidate

    Benzinga | Oct. 27, 2014 | 07:06AM EST
  3. Morning Market Movers

    Benzinga | Oct. 1, 2014 | 09:39AM EST
  4. US Stock Futures Edge Lower Ahead Of ADP Report

    Benzinga | Oct. 1, 2014 | 07:38AM EST
  5. Compugen Reports Results Further Confirming CGEN-15049 as 'Promising' Target Candidate for Cancer Immunotherapy

    Benzinga | Oct. 1, 2014 | 07:10AM EST
  6. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 8, 2014 | 08:09AM EST
  7. Benzinga's Top Initiations

    Benzinga | Jun. 18, 2014 | 09:16AM EST
  8. Morning Market Movers

    Benzinga | Jun. 16, 2014 | 09:40AM EST
  9. US Stock Futures Decline Ahead Of Economic Data

    Benzinga | Jun. 16, 2014 | 07:32AM EST
  10. Compugen Reports Positive Experimental Results for Novel Checkpoint Candidate CGEN-15052

    Benzinga | Jun. 16, 2014 | 07:05AM EST
  11. Morning Market Movers

    Benzinga | Mar. 19, 2014 | 09:36AM EST
  12. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 19, 2014 | 08:07AM EST
  13. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr

    Benzinga | Feb. 28, 2014 | 10:40AM EST
  14. Compugen Ltd. Prices 6M Share Public Offering at $10.50 per Share

    Benzinga | Feb. 28, 2014 | 09:17AM EST
  15. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 28, 2014 | 08:15AM EST
  16. Compugen to Significantly Expand Immuno-Oncology Activitiesin 2014

    Benzinga | Jan. 7, 2014 | 09:28AM EST
  17. Compugen, Bayer sign accord

    IBD | Aug. 5, 2013 | 18:43PM EST
  18. Market Wrap For Monday, August 5: Stocks Close Mixed; Nasdaq Rises, Dow And S&P Fall Modestly

    Benzinga | Aug. 5, 2013 | 16:38PM EST
  19. Morning Market Movers

    Benzinga | Aug. 5, 2013 | 10:01AM EST
  20. Compugen Shares Rocket Higher as Co. Announces Collaboration, License Deal with Bayer for Antibody-Based Cancer Immunotherapies

    Benzinga | Aug. 5, 2013 | 09:21AM EST
  21. Compugen Announces Discovery of Two Novel Immune Checkpoint Targets for Cancer Immunotherapy

    Benzinga | Oct. 31, 2012 | 02:24AM EST
  22. Compugen Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance

    Benzinga | Sep. 10, 2012 | 01:05AM EST
  23. Towers Watson &, Ubiquiti Networks Among Stocks hitting 52-Week Lows Tuesday

    FoxBusiness | Aug. 14, 2012 | 06:31AM EST
  24. Compugen Says Cancer Target Results Demonstrate Significant Potential for Cancer Immunotherapy

    Benzinga | Feb. 1, 2012 | 23:42PM EST
Trading Center